Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Molecular identity and cytotoxicity of Lenzites quercina macrofungus extracts toward cancer cell lines

The medicinal uses of wild macrofungi have been attributed to their accumulated bioactive compounds. Several mushrooms have been reported to possess antitumor activity, but little, in this regard, is known about Lenzites quercina collected from Akure in Nigeria. Hence, the molecular identification a...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2017
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/12783
042 |a dc 
720 |a Ogidi, O. C.  |e author 
720 |a Oyetayo, V. O.  |e author 
720 |a Akinyele, B. J.  |e author 
720 |a Ogbole, O. O.  |e author 
720 |a Adeniji, J. A.  |e author 
720 |a Oluremi B. B.  |e author 
260 |c 2017 
520 |a The medicinal uses of wild macrofungi have been attributed to their accumulated bioactive compounds. Several mushrooms have been reported to possess antitumor activity, but little, in this regard, is known about Lenzites quercina collected from Akure in Nigeria. Hence, the molecular identification and cytotoxic activity of extracts obtained from raw and fermented Lenzites quercina were assessed. The macrofungus Lenzites quercina was identified using Internal Transcribed Spacers (ITS) sequence analysis. The basic local alignment search tool (BLAST) analyzed on NCBI GenBank data revealed that the Lenzites species from Nigeria – accession number, JF689829.1 – was closely related to Lenzites quercina (a 100% relationship match). The cytotoxic activity of raw and fermented Lenzites quercina extracts was tested against human cervical cancer (HeLa), rhabdomyosarcoma (RD) and African green monkey kidney (VERO) cell lines. A tetrazolium yellow 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay was used to evaluate the reduction in viability of cell cultureswith or without the extracts of Lenzites quercina. Extracts of Lenzites quercina exhibited cytotoxic activity (6.0-84.5%) against the tested cancer cell lines (HeLa, VERO and RD). The concentration of the bioactive compounds in the crude extract ranged from 0.01 to 1000 μg/ml. The results revealed that bioactive compounds in Lenzites quercina possess cytotoxic properties. These bioactive compounds may be isolated and used as alternative therapies to currently available anticancer drugs. 
024 8 |a 0860-7796 
024 8 |a ui_art_ogidi_molecular_2017 
024 8 |a BioTechnologia 98(1), pp. 25-32 
024 8 |a https://repository.ui.edu.ng/handle/123456789/12783 
653 |a Lenzites quercina 
653 |a Chemotherapy 
653 |a Cancer cells 
653 |a MTT 
245 0 0 |a Molecular identity and cytotoxicity of Lenzites quercina macrofungus extracts toward cancer cell lines